Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
A Study of Psilocybin for PTSD
Johns Hopkins University
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Ohio State University
MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD
Dr. Leslie Morland
Group MDMA-therapy for Veterans With PTSD
Portland VA Research Foundation, Inc
Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD
Albany Research Institute, Inc.
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
COMPASS Pathways
Frontline Clinician Psilocybin Study
University of Washington
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
Remedy
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
VA Loma Linda Health Care System
Adding Trauma-focused Psychotherapy to Ketamine Treatment for Chronic PTSD
Icahn School of Medicine at Mount Sinai
Ketamine-enhanced Prolonged Exposure Therapy in PTSD
VA Office of Research and Development
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Lykos Therapeutics
Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD
Lykos Therapeutics
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Lykos Therapeutics
Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study
MAPS Europe B.V.
A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health
Field Trip Health
Chart Review of Patients Undergoing Ketamine Infusions
Brain and Cognition Discovery Foundation
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial
Yale University
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Lykos Therapeutics
Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD (Canada)
Lykos Therapeutics
Ketamine Infusion for Comorbid PTSD and Chronic Pain
VA Ann Arbor Healthcare System
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD
Lykos Therapeutics
MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD
Lykos Therapeutics
CAP-Ketamine for Antidepressant Resistant PTSD
VA Office of Research and Development
Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain
Defense and Veterans Center for Integrative Pain Management
Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD
Lykos Therapeutics
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
Lykos Therapeutics
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
Lykos Therapeutics
Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder
Lykos Therapeutics
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Dennis Charney
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
Lykos Therapeutics
MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
Lykos Therapeutics
MDMA Plus Exposure Therapy for PTSD
Emory University
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Medical University of Gdansk
A Multi-site Expanded Access Program for MDMA-assisted Psychotherapy for Patients With Treatment-resistant PTSD
Lykos Therapeutics
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
University of New Mexico
Mindfulness-based Psilocybin Therapy for PTSD
Anthony P King
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder
VA Office of Research and Development
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Unity Health Toronto
Psilocybin-Assisted Randomized Therapy
Emory University
MDMA-Assisted Massed Exposure Therapy for PTSD
Emory University
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Sunstone Medical
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Global Coalition for Adaptive Research
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSD
Suzanne "Sue" Sisley MD
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Johns Hopkins University
Ketamine, SGB and Combination Treatment for TBI
Northwestern University
Dose Optimization of MDMA-Assisted Therapy for PTSD
Bronx VA Medical Center
Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)
Nathan Brashares Sackett
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.